Charge Enterprises, Inc.

$ Overview Financials Valuation SEC Filings Company Website

2022 Q2 Form 10-Q Financial Statement

#000165495422006817 Filed on May 16, 2022

Income Statement

Concept	2022 Q2	2022 Q1	2021 Q4

Balance Sheet

Concept	2022 Q2	2022 Q1	2021 Q4
SHORT-TERM ASSETS
Cash & Short-Term Investments	$62.91M	$50.10M	$27.86M
YoY Change			87.22%
Cash & Equivalents	$46.58M	$26.38M	$18.24M
Short-Term Investments	$16.33M	$23.72M	$9.619M
Other Short-Term Assets	$11.29M	$8.828M	$6.534M
YoY Change
Inventory	$168.4K	$135.8K	$111.1K
Prepaid Expenses
Receivables	$75.07M	$68.92M	$73.33M
Other Receivables	$0.00	$0.00	$0.00
Total Short-Term Assets	$149.5M	$128.1M	$107.9M
YoY Change			35.33%
LONG-TERM ASSETS
Property, Plant & Equipment	$1.698M	$1.854M	$2.012M
YoY Change			13.39%
Goodwill	$36.02M		$26.05M
YoY Change			51.69%
Intangibles			$0.00
YoY Change
Long-Term Investments
YoY Change
Other Assets	$4.811M	$7.603M	$5.580M
YoY Change
Total Long-Term Assets	$57.77M	$58.46M	$35.67M
YoY Change			81.52%
TOTAL ASSETS
Total Short-Term Assets	$149.5M	$128.1M	$107.9M
Total Long-Term Assets	$57.77M	$58.46M	$35.67M
Total Assets	$207.3M	$186.5M	$143.6M
YoY Change			44.47%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$99.75M	$89.99M	$71.43M
YoY Change			2.17%
Accrued Expenses	$8.163M	$7.805M	$5.739M
YoY Change			630.98%
Deferred Revenue
YoY Change
Short-Term Debt	$2.757M	$0.00	$1.898M
YoY Change
Long-Term Debt Due	$159.2K	$2.860M	$2.860M
YoY Change
Total Short-Term Liabilities	$157.9M	$105.9M	$89.07M
YoY Change			15.96%
LONG-TERM LIABILITIES
Long-Term Debt	$22.39M	$29.70M	$30.78M
YoY Change
Other Long-Term Liabilities	$2.552M	$2.840M	$1.443M
YoY Change
Total Long-Term Liabilities	$24.94M	$32.54M	$32.22M
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities	$157.9M	$105.9M	$89.07M
Total Long-Term Liabilities	$24.94M	$32.54M	$32.22M
Total Liabilities	$182.8M	$138.4M	$121.3M
YoY Change			54.01%
SHAREHOLDERS EQUITY
Retained Earnings	-$175.2M	-$128.7M	-$111.4M
YoY Change			113.62%
Common Stock	$20.61K	$17.53M	$18.43K
YoY Change			-86.84%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$7.235M	$41.26M	$15.47M
YoY Change
Total Liabilities & Shareholders Equity	$207.3M	$186.5M	$143.6M
YoY Change			44.47%

Cashflow Statement

Concept	2022 Q2	2022 Q1	2021 Q4

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2022Q2	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	193079468	shares
CY2022Q1	crge	Investments In Non Marketable Securities InvestmentsInNonMarketableSecurities	100000	USD
CY2021Q4	crge	Investments In Non Marketable Securities InvestmentsInNonMarketableSecurities	100000	USD
CY2021Q1	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-1598563	USD
CY2022Q1	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	10000000	shares
CY2021Q4	crge	Finance Leases Liability FinanceLeasesLiability	159215	USD
CY2022Q1	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	4017788	USD
CY2022Q1	us-gaap	Liabilities Current LiabilitiesCurrent	105893723	USD
CY2021Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	1558052	USD
CY2022Q1	us-gaap	Noncurrent Assets NoncurrentAssets	232000	USD
CY2021Q4	us-gaap	Noncurrent Assets NoncurrentAssets	0	USD
CY2022Q1	us-gaap	Convertible Notes Payable ConvertibleNotesPayable	2700763	USD
CY2021Q4	us-gaap	Convertible Notes Payable ConvertibleNotesPayable	2700337	USD
CY2022Q1	us-gaap	Line Of Credit LineOfCredit	0	USD
CY2021Q4	us-gaap	Line Of Credit LineOfCredit	1898143	USD
CY2022Q1	crge	Finance Leases Liability FinanceLeasesLiability	159215	USD
CY2021Q4	us-gaap	Liabilities Current LiabilitiesCurrent	89068054	USD
CY2022Q1	us-gaap	Finance Lease Liability Noncurrent FinanceLeaseLiabilityNoncurrent	174115	USD
CY2021Q4	us-gaap	Finance Lease Liability Noncurrent FinanceLeaseLiabilityNoncurrent	218825	USD
CY2022Q1	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	2839860	USD
CY2021Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	1442743	USD
CY2022Q1	us-gaap	Notes Payable NotesPayable	24571333	USD
CY2021Q4	us-gaap	Notes Payable NotesPayable	26087523	USD
CY2022Q1	crge	Convertible Notes Payable Net Of Discount ConvertibleNotesPayableNetOfDiscount	4954219	USD
CY2021Q4	crge	Convertible Notes Payable Net Of Discount ConvertibleNotesPayableNetOfDiscount	4475260	USD
CY2022Q1	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.0001
CY2022Q1	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	10000000	shares
CY2022Q1	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2022Q1	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	750000000	shares
CY2022Q1	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	189788747	shares
CY2022Q1	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	184266934	shares
CY2022Q1	crge	Common Stock To Be Issued CommonStockToBeIssued	6587897	shares
CY2022Q1	crge	Common Stocks To Be Issued CommonStocksToBeIssued	658	USD
CY2021Q4	crge	Common Stocks To Be Issued CommonStocksToBeIssued	658	USD
CY2021Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	126869604	USD
CY2021Q4	us-gaap	Accumulated Other Comprehensive Income Loss Before Tax1 AccumulatedOtherComprehensiveIncomeLossBeforeTax1	-32289	USD
CY2021Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-111389529	USD
CY2022Q1	crge	Stockholder Equity StockholderEquity	41259225	USD
CY2021Q4	crge	Stockholder Equity StockholderEquity	15467107	USD
CY2022Q1	us-gaap	Share Based Compensation ShareBasedCompensation	10743632	USD
CY2021Q1	us-gaap	Share Based Compensation ShareBasedCompensation	4563196	USD
CY2022Q1	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	2996684	USD
CY2021Q1	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	1299287	USD
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	15467107	USD
CY2021Q1	us-gaap	Gross Profit GrossProfit	1618321	USD
CY2021Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	143609512	USD
CY2022Q1	us-gaap	Revenues Revenues	162977890	USD
CY2021Q1	us-gaap	Revenues Revenues	111127641	USD
CY2022Q1	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	156507632	USD
CY2021Q1	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	109509320	USD
CY2022Q1	us-gaap	Gross Profit GrossProfit	6470258	USD
CY2022Q1	us-gaap	Labor And Related Expense LaborAndRelatedExpense	4242681	USD
CY2021Q1	us-gaap	Labor And Related Expense LaborAndRelatedExpense	832384	USD
CY2022Q1	us-gaap	Depreciation Depreciation	209054	USD
CY2021Q1	us-gaap	Depreciation Depreciation	49947	USD
CY2022Q1	us-gaap	Operating Expenses OperatingExpenses	19256538	USD
CY2021Q1	us-gaap	Operating Expenses OperatingExpenses	6991966	USD
CY2022Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	-12786280	USD
CY2021Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	-5373645	USD
CY2022Q1	us-gaap	Net Investment Income NetInvestmentIncome	-110006	USD
CY2021Q1	us-gaap	Net Investment Income NetInvestmentIncome	3401714	USD
CY2022Q1	crge	Amortization Of Debt Discount Related Party AmortizationOfDebtDiscountRelatedParty	-1029597	USD
CY2021Q1	crge	Amortization Of Debt Discount Related Party AmortizationOfDebtDiscountRelatedParty	-61874	USD
CY2022Q1	us-gaap	Interest Expense InterestExpense	735053	USD
CY2021Q1	us-gaap	Interest Expense InterestExpense	181002	USD
CY2022Q1	crge	Foreign Exchange Adjustments ForeignExchangeAdjustments	-255602	USD
CY2021Q1	crge	Foreign Exchange Adjustments ForeignExchangeAdjustments	-451478	USD
CY2022Q1	crge	Total Other Expenses Net TotalOtherExpensesNet	-1931905	USD
CY2021Q1	crge	Total Other Expenses Net TotalOtherExpensesNet	2611903	USD
CY2022Q1	us-gaap	Income Loss From Subsidiaries Tax Expense Benefit IncomeLossFromSubsidiariesTaxExpenseBenefit	-14718185	USD
CY2021Q1	us-gaap	Income Loss From Subsidiaries Tax Expense Benefit IncomeLossFromSubsidiariesTaxExpenseBenefit	-2761742	USD
CY2022Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-1578283	USD
CY2021Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-1182635	USD
CY2022Q1	crge	Net Loss NetLoss	-13139902	USD
CY2021Q1	crge	Net Loss NetLoss	-1579107	USD
CY2022Q1	crge	Deemed Dividend DeemedDividend	-3856000	USD
CY2022Q1	us-gaap	Dividends Preferred Stock DividendsPreferredStock	266987	USD
CY2021Q1	crge	Deemed Dividend DeemedDividend	0	USD
CY2022Q1	crge	Net Income Loss Available To Common Stockholders NetIncomeLossAvailableToCommonStockholders	-17262889	USD
CY2021Q1	crge	Net Income Loss Available To Common Stockholders NetIncomeLossAvailableToCommonStockholders	-1579107	USD
CY2022Q1	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.09
CY2021Q1	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.01
CY2022Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	188408616	shares
CY2021Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	147806984	shares
CY2022Q1	crge	Net Loss NetLoss	-13139902	USD
CY2021Q1	crge	Net Loss NetLoss	-1579107	USD
CY2022Q1	us-gaap	Temporary Equity Foreign Currency Translation Adjustments TemporaryEquityForeignCurrencyTranslationAdjustments	105	USD
CY2022Q1	us-gaap	Other Comprehensive Income Other Net Of Tax OtherComprehensiveIncomeOtherNetOfTax	105	USD
CY2021Q1	us-gaap	Other Comprehensive Income Other Net Of Tax OtherComprehensiveIncomeOtherNetOfTax	-19456	USD
CY2022Q1	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-13139797	USD
CY2020Q4	us-gaap	Stockholders Equity StockholdersEquity	20653095	USD
CY2022Q1	crge	Stock Based Compensation Expense Amount StockBasedCompensationExpenseAmount	10743632	USD
CY2022Q1	us-gaap	Dividends Cash DividendsCash	266984	USD
CY2022Q1	crge	Series C Preferred Stock Member Amount SeriesCPreferredStockMemberAmount	12050000	USD
CY2022Q1	crge	Beneficial Conversion Feature Arising From Preferred Stock Amount BeneficialConversionFeatureArisingFromPreferredStockAmount	2651000	USD
CY2022Q1	crge	Deemed Dividend In Connection With Series C Preferred Stock Amount DeemedDividendInConnectionWithSeriesCPreferredStockAmount	-3856000	USD
CY2022Q1	crge	Common Stock Issued For Acquisition Amount CommonStockIssuedForAcquisitionAmount	17530278	USD
CY2022Q1	us-gaap	Conversion Of Stock Amount Issued1 ConversionOfStockAmountIssued1	79990	USD
CY2022Q1	us-gaap	Net Income Loss NetIncomeLoss	-13139797	USD
CY2022Q1	us-gaap	Stockholders Equity StockholdersEquity	41259226	USD
CY2021Q1	crge	Shares Of Common Stock From Prior Year Issued Amount SharesOfCommonStockFromPriorYearIssuedAmount	0	USD
CY2021Q1	crge	Common Stock Issued For Services Amount CommonStockIssuedForServicesAmount	167348	USD
CY2021Q1	crge	Conversion Of Debt And Accrued Interest Amount ConversionOfDebtAndAccruedInterestAmount	1010650	USD
CY2021Q1	crge	Stock Based Compensation Expense Amount StockBasedCompensationExpenseAmount	4563197	USD
CY2021Q1	crge	Adjustment To Par Value AdjustmentToParValue	0	USD
CY2021Q1	us-gaap	Net Income Loss NetIncomeLoss	-1598563	USD
CY2021Q1	us-gaap	Stockholders Equity StockholdersEquity	24795727	USD
CY2022Q1	us-gaap	Profit Loss ProfitLoss	-13139903	USD
CY2021Q1	us-gaap	Profit Loss ProfitLoss	-1579107	USD
CY2022Q1	us-gaap	Depreciation And Amortization DepreciationAndAmortization	209054	USD
CY2021Q1	us-gaap	Depreciation And Amortization DepreciationAndAmortization	49947	USD
CY2022Q1	crge	Stock Based Compensation StockBasedCompensation	10743633	USD
CY2021Q1	crge	Stock Based Compensation StockBasedCompensation	4689940	USD
CY2022Q1	us-gaap	Increase Decrease In Derivative Liabilities IncreaseDecreaseInDerivativeLiabilities	0	USD
CY2021Q1	us-gaap	Increase Decrease In Derivative Liabilities IncreaseDecreaseInDerivativeLiabilities	330	USD
CY2022Q1	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	1029597	USD
CY2021Q1	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	61874	USD
CY2022Q1	us-gaap	Amortization Of Financing Costs And Discounts AmortizationOfFinancingCostsAndDiscounts	0	USD
CY2021Q1	us-gaap	Amortization Of Financing Costs And Discounts AmortizationOfFinancingCostsAndDiscounts	95127	USD
CY2022Q1	us-gaap	Foreign Currency Transaction Gain Loss Realized ForeignCurrencyTransactionGainLossRealized	255602	USD
CY2021Q1	us-gaap	Foreign Currency Transaction Gain Loss Realized ForeignCurrencyTransactionGainLossRealized	451478	USD
CY2022Q1	crge	Net Income From Investments NetIncomeFromInvestments	110006	USD
CY2021Q1	crge	Net Income From Investments NetIncomeFromInvestments	-3401714	USD
CY2022Q1	us-gaap	Other Operating Income Expense Net OtherOperatingIncomeExpenseNet	-188227	USD
CY2021Q1	us-gaap	Other Operating Income Expense Net OtherOperatingIncomeExpenseNet	0	USD
CY2022Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-1578283	USD
CY2021Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-1182635	USD
CY2022Q1	us-gaap	Accounts Receivable Sale AccountsReceivableSale	4265706	USD
CY2021Q1	us-gaap	Accounts Receivable Sale AccountsReceivableSale	21528860	USD
CY2022Q1	crge	Increase Decrease In Accrued Revenue IncreaseDecreaseInAccruedRevenue	3842574	USD
CY2021Q1	crge	Increase Decrease In Accrued Revenue IncreaseDecreaseInAccruedRevenue	0	USD
CY2022Q1	us-gaap	Increase Decrease In Deposit Other Assets IncreaseDecreaseInDepositOtherAssets	-220917	USD
CY2021Q1	us-gaap	Increase Decrease In Deposit Other Assets IncreaseDecreaseInDepositOtherAssets	51578	USD
CY2022Q1	crge	Increase Decrease In Other Assets IncreaseDecreaseInOtherAssets	-129000	USD
CY2021Q1	crge	Increase Decrease In Other Assets IncreaseDecreaseInOtherAssets	0	USD
CY2022Q1	crge	Costs In Excess Of Billings On Uncompleted Contracts Or Programs1 CostsInExcessOfBillingsOnUncompletedContractsOrPrograms1	5615835	USD
CY2021Q1	crge	Costs In Excess Of Billings On Uncompleted Contracts Or Programs1 CostsInExcessOfBillingsOnUncompletedContractsOrPrograms1	0	USD
CY2022Q1	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	17875870	USD
CY2021Q1	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	-11321223	USD
CY2022Q1	crge	Increase Decrease In Accrued Expenses IncreaseDecreaseInAccruedExpenses	-352222	USD
CY2021Q1	crge	Increase Decrease In Accrued Expenses IncreaseDecreaseInAccruedExpenses	-9694135	USD
CY2022Q1	us-gaap	Increase Decrease In Other Current Liabilities IncreaseDecreaseInOtherCurrentLiabilities	-166984	USD
CY2021Q1	us-gaap	Increase Decrease In Other Current Liabilities IncreaseDecreaseInOtherCurrentLiabilities	0	USD
CY2022Q1	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue	-2225122	USD
CY2021Q1	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue	0	USD
CY2022Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	14715549	USD
CY2021Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-249680	USD
CY2022Q1	us-gaap	Acquisition Costs AcquisitionCosts	34942	USD
CY2021Q1	us-gaap	Acquisition Costs AcquisitionCosts	266096	USD
CY2022Q1	us-gaap	Gain Loss On Sale Of Properties GainLossOnSaleOfProperties	127486	USD
CY2021Q1	us-gaap	Payments To Acquire Marketable Securities PaymentsToAcquireMarketableSecurities	25213283	USD
CY2022Q1	us-gaap	Proceeds From Sale And Maturity Of Marketable Securities ProceedsFromSaleAndMaturityOfMarketableSecurities	28401415	USD
CY2021Q1	us-gaap	Proceeds From Sale And Maturity Of Marketable Securities ProceedsFromSaleAndMaturityOfMarketableSecurities	25213283	USD
CY2022Q1	us-gaap	Finance Lease Principal Payments FinanceLeasePrincipalPayments	26601	USD
CY2022Q1	us-gaap	Investment Income Net InvestmentIncomeNet	-1231250	USD
CY2021Q1	us-gaap	Investment Income Net InvestmentIncomeNet	0	USD
CY2021Q1	us-gaap	Finance Lease Principal Payments FinanceLeasePrincipalPayments	0	USD
CY2022Q1	us-gaap	Cash Acquired From Acquisition CashAcquiredFromAcquisition	104485	USD
CY2021Q1	us-gaap	Cash Acquired From Acquisition CashAcquiredFromAcquisition	0	USD
CY2022Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-15247031	USD
CY2022Q1	us-gaap	Payments Of Dividends PaymentsOfDividends	260798	USD
CY2021Q1	us-gaap	Payments Of Dividends PaymentsOfDividends	0	USD
CY2022Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	8659458	USD
CY2021Q1	us-gaap	Gain Loss On Sale Of Properties GainLossOnSaleOfProperties	0	USD
CY2022Q1	us-gaap	Payments To Acquire Marketable Securities PaymentsToAcquireMarketableSecurities	42614225	USD
CY2021Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	0	USD
CY2022Q1	crge	Foreign Currency Adjustment ForeignCurrencyAdjustment	14998	USD
CY2021Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-266096	USD
CY2022Q1	crge	Proceeds From Sale Of Series C Preferred Stock ProceedsFromSaleOfSeriesCPreferredStock	10845000	USD
CY2022Q1	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.0001
CY2021Q1	crge	Proceeds From Sale Of Series C Preferred Stock ProceedsFromSaleOfSeriesCPreferredStock	0	USD
CY2022Q1	us-gaap	Proceeds From Lines Of Credit ProceedsFromLinesOfCredit	1898143	USD
CY2021Q1	us-gaap	Proceeds From Lines Of Credit ProceedsFromLinesOfCredit	0	USD
CY2021Q1	crge	Foreign Currency Adjustment ForeignCurrencyAdjustment	0	USD
CY2022Q1	us-gaap	Cash Period Increase Decrease CashPeriodIncreaseDecrease	8142974	USD
CY2021Q1	us-gaap	Cash Period Increase Decrease CashPeriodIncreaseDecrease	-515776	USD
CY2021Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	18238264	USD
CY2020Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	11629303	USD
CY2022Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	26381238	USD
CY2021Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	11113527	USD
CY2022Q1	us-gaap	Interest Paid Net InterestPaidNet	731715	USD
CY2021Q1	us-gaap	Interest Paid Net InterestPaidNet	110123	USD
CY2022Q1	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	0	USD
CY2021Q1	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	0	USD
CY2022Q1	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	17530278	USD
CY2021Q1	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	0	USD
CY2022Q1	us-gaap	Nature Of Operations NatureOfOperations	<p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;"><strong>Note 1 Nature of operations</strong></p><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;">Charge Enterprises, Inc., through its subsidiaries (sometimes referred to herein as “we,” “us,” “our,” “Charge” or the “Company”) consists of a portfolio of global businesses with a vision to build the electrification and telecommunications infrastructure that will address and service requirements for EVC (“Electrical Vehicle Charging”) and WNI (“Wireless Network Infrastructure”) which includes 5G, tower, distributed antennae systems (“DAS”), small cell, and electrical infrastructure. </p><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;">The Company operates in two segments: Telecommunications, which provides connection of voice calls and data to global carriers and Infrastructure which builds physical wireless network elements, provides electrical construction services and designs and installs EV charging stations and infrastructure. Financial information about each business segment is contained in “Note 13- Reportable segments” to the consolidated financial statements.</p>
CY2022Q1	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	9373442	USD
CY2021Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	9372253	USD
CY2022Q1	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	7519148	USD
CY2021Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	7360584	USD
CY2022Q1	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	1854294	USD
CY2021Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	2011668	USD
CY2022Q1	us-gaap	Depreciation Depreciation	209054	USD
CY2021Q1	us-gaap	Depreciation Depreciation	49947	USD
CY2022Q1	us-gaap	Marketable Securities MarketableSecurities	23721546	USD
CY2021Q4	us-gaap	Marketable Securities MarketableSecurities	9618743	USD
CY2022Q1	us-gaap	Dilutive Securities DilutiveSecurities	24057356	USD
CY2021	us-gaap	Dilutive Securities DilutiveSecurities	10549524	USD
CY2022Q1	us-gaap	Unrealized Gain On Securities UnrealizedGainOnSecurities	0	USD
CY2021	us-gaap	Unrealized Gain On Securities UnrealizedGainOnSecurities	0	USD
CY2022Q1	us-gaap	Unrealized Loss On Securities UnrealizedLossOnSecurities	335810	USD
CY2021	us-gaap	Unrealized Loss On Securities UnrealizedLossOnSecurities	930781	USD
CY2022Q1	crge	Fair Value Of Assets FairValueOfAssets	23721546	USD
CY2021	crge	Fair Value Of Assets FairValueOfAssets	9618743	USD
CY2022Q1	crge	Net Gains Within Net Income From Investments On Statement Of Operations NetGainsWithinNetIncomeFromInvestmentsOnStatementOfOperations	110006	USD
CY2022Q1	crge	Unrealized Losses UnrealizedLosses	270438	USD
CY2022Q1	crge	Realized Gains RealizedGains	160432	USD
CY2021Q1	crge	Net Gains Within Net Income From Investments On Statement Of Operations NetGainsWithinNetIncomeFromInvestmentsOnStatementOfOperations	3401714	USD
CY2021Q1	crge	Unrealized Losses UnrealizedLosses	197464	USD
CY2021Q1	crge	Realized Gains RealizedGains	3204250	USD
CY2022Q1	us-gaap	Payments To Acquire Businesses Gross PaymentsToAcquireBusinessesGross	1231250	USD
CY2022Q1	us-gaap	Accrued Liabilities Fair Value Disclosure AccruedLiabilitiesFairValueDisclosure	18750	USD
CY2022Q1	us-gaap	Asset Acquisition Contingent Consideration Liability AssetAcquisitionContingentConsiderationLiability	6827	USD
CY2022Q1	us-gaap	Common Stock Value CommonStockValue	17530278	USD
CY2022Q1	us-gaap	Business Combination Consideration Transferred1 BusinessCombinationConsiderationTransferred1	18787105	USD
CY2022Q1	crge	Convertible Notes Payable Amount ConvertibleNotesPayableAmount	12498889	USD
CY2021	crge	Convertible Notes Payable Amount ConvertibleNotesPayableAmount	12565289	USD
CY2022Q1	crge	Less Unamortized Discount And Debt Issue Costs LessUnamortizedDiscountAndDebtIssueCosts	-4843907	USD
CY2021	crge	Less Unamortized Discount And Debt Issue Costs LessUnamortizedDiscountAndDebtIssueCosts	-5389693	USD
CY2022Q1	us-gaap	Repayments Of Notes Payable RepaymentsOfNotesPayable	7654982	USD
CY2021	us-gaap	Repayments Of Notes Payable RepaymentsOfNotesPayable	7175597	USD
CY2022Q1	crge	Interest Expenses Convertible Notes Payable InterestExpensesConvertibleNotesPayable	247076	USD
CY2021Q4	crge	Interest Expenses Convertible Notes Payable InterestExpensesConvertibleNotesPayable	146467	USD
CY2022Q1	crge	Debt Instrument Unamortized Discount Convertible Notes Payable DebtInstrumentUnamortizedDiscountConvertibleNotesPayable	545786	USD
CY2021Q4	crge	Debt Instrument Unamortized Discount Convertible Notes Payable DebtInstrumentUnamortizedDiscountConvertibleNotesPayable	61874	USD
CY2022Q1	us-gaap	Accumulated Amortization Deferred Finance Costs AccumulatedAmortizationDeferredFinanceCosts	0	USD
CY2021Q4	us-gaap	Accumulated Amortization Deferred Finance Costs AccumulatedAmortizationDeferredFinanceCosts	7397	USD
CY2022Q1	crge	Interest Expense And Amortization Of Debt Discount And Debt Issuance Costs InterestExpenseAndAmortizationOfDebtDiscountAndDebtIssuanceCosts	792862	USD
CY2021Q4	crge	Interest Expense And Amortization Of Debt Discount And Debt Issuance Costs InterestExpenseAndAmortizationOfDebtDiscountAndDebtIssuanceCosts	215738	USD
CY2022Q1	us-gaap	Convertible Long Term Notes Payable ConvertibleLongTermNotesPayable	175178	USD
CY2021Q4	us-gaap	Convertible Long Term Notes Payable ConvertibleLongTermNotesPayable	183067	USD
CY2022Q1	crge	Paycheck Protection Program Loans PaycheckProtectionProgramLoans	2000000	USD
CY2022Q1	crge	Interest Expenses InterestExpenses	0	USD
CY2021Q4	crge	Interest Expenses InterestExpenses	6019	USD
CY2022Q1	us-gaap	Debt Instrument Unamortized Discount DebtInstrumentUnamortizedDiscount	0	USD
CY2021Q4	us-gaap	Debt Instrument Unamortized Discount DebtInstrumentUnamortizedDiscount	95127	USD
CY2022Q1	crge	Interest Expense And Amortization Of Debt Discount InterestExpenseAndAmortizationOfDebtDiscount	0	USD
CY2021Q4	crge	Interest Expense And Amortization Of Debt Discount InterestExpenseAndAmortizationOfDebtDiscount	101146	USD
CY2020Q3	us-gaap	Convertible Notes Payable ConvertibleNotesPayable	288889	USD
CY2022Q1	crge	Korr Value Converted KorrValueConverted	261111	USD
CY2022Q1	crge	Paycheck Protection Program Loan PaycheckProtectionProgramLoan	0	USD
CY2021Q4	crge	Paycheck Protection Program Loan PaycheckProtectionProgramLoan	2000000	USD
CY2022Q1	crge	Notes Payable Issued NotesPayableIssued	11860055	USD
CY2021Q4	crge	Notes Payable Issued NotesPayableIssued	11860055	USD
CY2022Q1	crge	Notes Payable Issued December NotesPayableIssuedDecember	15925926	USD
CY2021Q4	crge	Notes Payable Issued December NotesPayableIssuedDecember	15925926	USD
CY2022Q1	crge	Unamortized Discount And Debt Issue Cost UnamortizedDiscountAndDebtIssueCost	-3214648	USD
CY2021Q4	crge	Unamortized Discount And Debt Issue Cost UnamortizedDiscountAndDebtIssueCost	-3698458	USD
CY2022Q1	us-gaap	Notes Payable NotesPayable	24571333	USD
CY2021Q4	us-gaap	Notes Payable NotesPayable	26087523	USD
CY2021Q4	crge	Paycheck Protection Program Loans PaycheckProtectionProgramLoans	2000000	USD
CY2022Q1	crge	Reimburse Sba Loan ReimburseSBALoan	2000000	USD
CY2021Q1	us-gaap	Depreciation And Amortization DepreciationAndAmortization	49947	USD
CY2022Q1	crge	Capital Expenditures CapitalExpenditures	34942	USD
CY2021Q1	crge	Capital Expenditures CapitalExpenditures	1355297	USD
CY2022Q1	crge	Total Investments TotalInvestments	23821546	USD
CY2022Q1	crge	Interest Expense And Amortisation Debt Discount InterestExpenseAndAmortisationDebtDiscount	<table cellpadding="0" style="border-spacing:0;text-align:left;font:10pt times new roman;width:100%"><tbody><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" colspan="6" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Three months ended March 31,</strong></p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>2022</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>2021</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Interest Expense </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">484,639</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">-</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Amortization of debt discount</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">483,810</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">-</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> Total </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 3px double;width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="BORDER-BOTTOM: 3px double;width:9%;vertical-align:bottom;text-align:right;">968,449</td><td style="PADDING-BOTTOM: 3px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 3px double;width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="BORDER-BOTTOM: 3px double;width:9%;vertical-align:bottom;text-align:right;">-</td><td style="PADDING-BOTTOM: 3px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr></tbody></table><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;">The accrued interest relating to the notes payable as of March 31, 2022 and December 2021 was $161,546 and $115,250, respectively.</p>
CY2022Q1	crge	Interest Expenses C Onvertible Notes Payable Related Parties InterestExpensesCOnvertibleNotesPayableRelatedParties	484639	USD
CY2021Q4	crge	Interest Expenses C Onvertible Notes Payable Related Parties InterestExpensesCOnvertibleNotesPayableRelatedParties	0	USD
CY2022Q1	crge	Debt Instrument Unamortized Discount Notes Payable DebtInstrumentUnamortizedDiscountNotesPayable	483810	USD
CY2021Q4	crge	Debt Instrument Unamortized Discount Notes Payable DebtInstrumentUnamortizedDiscountNotesPayable	0	USD
CY2022Q1	us-gaap	Deferred Finance Costs Net DeferredFinanceCostsNet	968449	USD
CY2021Q4	us-gaap	Deferred Finance Costs Net DeferredFinanceCostsNet	0	USD
CY2022Q1	crge	Accrued Interest Notes AccruedInterestNotes	161546	USD
CY2021Q4	crge	Accrued Interest Notes AccruedInterestNotes	115250	USD
CY2021	crge	Description Of Provision DescriptionOfProvision	provision expired on June 1, 2021
CY2021Q1	us-gaap	Derivative Liabilities DerivativeLiabilities	330	USD
CY2022Q1	us-gaap	Sales Type Lease Revenue SalesTypeLeaseRevenue	1100000	USD
CY2022Q1	crge	Revenue From Telecommunications RevenueFromTelecommunications	526662	USD
CY2021Q1	crge	Revenue From Telecommunications RevenueFromTelecommunications	689470	USD
CY2022Q1	crge	Revenue From Infrastructure RevenueFromInfrastructure	1636816	USD
CY2021Q1	crge	Revenue From Infrastructure RevenueFromInfrastructure	-468518	USD
CY2022Q1	us-gaap	Depreciation And Amortization DepreciationAndAmortization	209054	USD
CY2021	crge	Total Investments TotalInvestments	9718743	USD
CY2022Q1	us-gaap	Assets Assets	186542475	USD
CY2021Q4	us-gaap	Assets Assets	143609512	USD
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	44920000	shares
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	1.78
CY2022Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	2550000	shares
CY2022Q1	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	3.47
CY2022Q1	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice	0
CY2022Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod	565000	shares
CY2022Q1	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice	3.16
CY2022Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	46905000	shares
CY2022Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	1.85
CY2022Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber	14737501	shares
CY2022Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice	1.14
CY2022Q1	us-gaap	Sharebased Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Outstanding Options Weighted Average Remaining Contractual Term2 SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2	P5Y1M24D
CY2022Q1	crge	Unrecognized Costs Related To Stock Options Granted UnrecognizedCostsRelatedToStockOptionsGranted	42426783	USD
CY2022Q1	us-gaap	Time Deposits At Or Above Fdic Insurance Limit TimeDepositsAtOrAboveFDICInsuranceLimit	250000	USD
CY2022Q1	us-gaap	Time Deposit Liability Above Us Insurance Limit TimeDepositLiabilityAboveUsInsuranceLimit	24111296	USD
CY2021Q4	us-gaap	Time Deposit Liability Above Us Insurance Limit TimeDepositLiabilityAboveUsInsuranceLimit	17503737	USD
CY2022Q1	crge	Income Loss Before Income Tax Benefit IncomeLossBeforeIncomeTaxBenefit	-14718191	USD
CY2021Q1	crge	Income Loss Before Income Tax Benefit IncomeLossBeforeIncomeTaxBenefit	-2761742	USD
CY2022Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-1578283	USD
CY2021Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-1182635	USD
CY2022Q1	us-gaap	Effective Income Tax Rate Reconciliation Tax Credits EffectiveIncomeTaxRateReconciliationTaxCredits	-0.107	pure
CY2021Q1	us-gaap	Effective Income Tax Rate Reconciliation Tax Credits EffectiveIncomeTaxRateReconciliationTaxCredits	-0.428	pure
CY2022Q2	us-gaap	Sale Of Stock Price Per Share SaleOfStockPricePerShare	8.50
CY2022Q2	crge	Aggregate Purchase Price AggregatePurchasePrice	10000025	USD

Files In Submission

Name	View Source	Status
0001654954-22-006817-index-headers.html	Edgar Link	pending
0001654954-22-006817-index.html	Edgar Link	pending
0001654954-22-006817.txt	Edgar Link	pending
0001654954-22-006817-xbrl.zip	Edgar Link	pending
crge-20220331.xsd	Edgar Link	pending
crge-20220331_cal.xml	Edgar Link	unprocessable
crge-20220331_def.xml	Edgar Link	unprocessable
crge-20220331_lab.xml	Edgar Link	unprocessable
crge-20220331_pre.xml	Edgar Link	unprocessable
crge_10q.htm	Edgar Link	pending
crge_10q_htm.xml	Edgar Link	completed
crge_ex311.htm	Edgar Link	pending
crge_ex312.htm	Edgar Link	pending
crge_ex321.htm	Edgar Link	pending
crge_ex322.htm	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
Financial_Report.xlsx	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R62.htm	Edgar Link	pending
R63.htm	Edgar Link	pending
R64.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

Charge Enterprises, Inc.

2022 Q2 Form 10-Q Financial Statement

#000165495422006817 Filed on May 16, 2022

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission